Journal of Digestive Endoscopy

LinksSchließen

Referenz

Moayyedi P, Eikelboom JW, Bosch J. et al.
COMPASS Investigators. Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial.

Gastroenterology 2019;
157 (02) 403-412.e5

Bibliographische Angaben herunterladen

Aufrufen in: